SEP 0226332
Alternative Names: SEP 226332Latest Information Update: 11 Jul 2007
At a glance
- Originator Sepracor
- Class
- Mechanism of Action Serotonin 3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Sleep disorders
Most Recent Events
- 14 Jan 2004 Phase-I clinical trials in Sleep disorders in USA (unspecified route)